InvestorsHub Logo

EM

07/31/17 5:40 PM

#5890 RE: Amatuer17 #5889

Don't know the other two names but Kitov is up 85% since the recent offering. If there's a time to be a Kitov's shareholder is now.

Good luck

Amatuer17

07/31/17 8:04 PM

#5896 RE: Amatuer17 #5889

Submitting NDA is a big deal for any company - more so for such a small company.

Also the icing on cake - $ 2 million registration fee waiver

"TEL AVIV, Israel, April 3, 2017 /PRNewswire/ --

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has granted Kitov a waiver related to the $2,038,100 New Drug Application (NDA 210045) filing fee for KIT-302.
KIT-302 is Kitov's patented combination of Amlodipine Besylate-Celecoxib tablets, intended to treat osteoarthritis pain and hypertension simultaneously. "